Fyremadel Injection, Solution
Product Images NDC 55566-1010

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fyremadel (NDC 55566-1010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fyremadel 01)

Chemical structure diagram showing the peptide sequence and side chains of ganirelix acetate, the active ingredient in Fyremadel injection, solution. The structure includes amino acid residues and chemical groups relevant to ganirelix acetate's molecular composition.*

FDA Label Image

Principal Display Panel (250 mcg/0.5 mL Syringe Blister Pack Carton)

Fyremadel 250 mcg/0.5 mL injection label for subcutaneous use. The label indicates a single-dose sterile prefilled syringe, 27 gauge with a 1/2 inch needle. Manufactured by Sun Pharmaceutical Industries Ltd. and distributed by Ferring Pharmaceuticals Inc. The label includes dosage information, storage instructions, regulatory markings, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.